Markets:

Overview

News

Currencies

International

Treasuries

Boston Scientific (NY:BSX)

69.48 -0.41 (-0.59%)

Official Closing Price Updated: 7:00 PM EDT, Mar 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips

March 19, 2026

As the first quarter of 2026 draws to a close, the U.S. financial landscape has been reshaped by a staggering surge in corporate consolidation. Total deal value for the quarter reached a historic...

Via MarketMinute

BOSTON SCIENTIFIC CORPORATION (BSX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline

March 19, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

BSX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026

March 18, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Boston Scientific Corp (NYSE:BSX): A GARP Stock with Strong Growth and Reasonable Valuation ↗

March 12, 2026

Via Chartmill

The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms

March 18, 2026

In the face of the most aggressive antitrust environment in decades and the sweeping legislative changes of the 2025 "One Big Beautiful Bill Act" (OBBBA), the healthcare sector has not retreated from...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX

March 17, 2026

From Pomerantz LLP

Via GlobeNewswire

BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Executives Misrepresented U.S. Electrophysiology Volumes: Levi & Korsinsky

March 17, 2026

From Levi & Korsinsky, LLP

Via Business Wire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)

March 17, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Movers and shakers in today's after-hours session for S&P500 stocks? ↗

March 16, 2026

Via Chartmill

Which stocks are moving after the closing bell on Monday? ↗

March 16, 2026

Via Chartmill

INVESTOR NOTICE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

March 16, 2026

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗

March 15, 2026

EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.

Via The Motley Fool

This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗

March 15, 2026

This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide.

Via The Motley Fool

Topics Regulatory Compliance

This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares ↗

March 15, 2026

This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest filing.

Via The Motley Fool

This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share ↗

March 15, 2026

RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials.

Via The Motley Fool

Deadline Alert: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

March 12, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

BOSTON SCIENTIFIC CORPORATION (BSX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline

March 12, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Medical Technology Alert: BSX, TFX, ARAY, CSDX, NDRA Emerging Across Cancer Treatment and GLP-1 Healthcare Ecosystems

March 11, 2026

Via AB Newswire

This $9 Million Institutional Buy Targeted a Semiconductor Stock Down 19% Over the Past Year ↗

March 11, 2026

Skyworks Solutions delivers semiconductor products for wireless and analog applications across diverse global markets.

Via The Motley Fool

Topics Regulatory Compliance

OLED Stock Down 35% This Past Year, but One Fund Invested $9 Million More Anyway ↗

March 11, 2026

Universal Display licenses OLED tech and supplies materials to major players in the global display and lighting markets.

Via The Motley Fool

Topics Intellectual Property Regulatory Compliance

Deadline Approaching: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

March 11, 2026

From Law Offices of Howard G. Smith

Via Business Wire

1 Profitable Stock to Research Further and 2 Facing Challenges

March 11, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

BOSTON SCIENTIFIC ALERT: Bragar Eagel & Squire, P.C. is Investigating Boston Scientific Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

March 10, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX

March 10, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Unsustainable U.S. Electrophysiology Segment Growth Rate: Levi & Korsinsky

March 10, 2026

From Levi & Korsinsky, LLP

Via Business Wire

The $2.5 Trillion Tsunami: Why 2026 has Become the Year of the Megadeal

March 10, 2026

As of March 10, 2026, the United States financial markets are witnessing an unprecedented explosion in Mergers and Acquisitions (M&A) that has caught even the most optimistic analysts by surprise....

Via MarketMinute

Topics Artificial Intelligence Economy Government

Law Offices of Frank R. Cruz Encourages Boston Scientific Corporation (BSX) Shareholders To Inquire About Securities Fraud Class Action

March 10, 2026

From Law Offices of Frank R. Cruz

Via Business Wire

Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims

March 10, 2026

From Grabar Law Office

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)

March 10, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

The 2026 M&A Resurgence: Private Equity Confidence Hits Record Highs

March 09, 2026

The U.S. Mergers and Acquisitions (M&A) landscape has entered a blistering new phase of activity, shaking off the volatility of the mid-2020s to reach levels of engagement not seen in over half a...

Via MarketMinute

Topics Artificial Intelligence Economy Government

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.